Wilmington, Del.-based Nemours Children’s Health received a five-year, $5.32 million grant from the National Institutes of Health to expand sickle cell disease research.
The funding will support the third phase of research at the Delaware Comprehensive Sickle Cell Research Center, including up to eight one-year pilot projects and expanded use of bioinformatics.
The award follows two previous grants for the initiative: $10.2 million in 2014 and $10.5 million in 2021. Earlier funding supported studies examining use of sickle cell therapies among adolescents and young adults, blood vessel damage associated with the disease and communication of newborn screening results that indicate sickle cell trait.
David Brousseau, MD, pediatrician-in-chief and director of research at Nemours Children’s Health, Delaware Valley, and Robin Miller, MD, director of the system’s sickle cell disease program, received the latest grant.
The $5.32 million award is separate from the more than $10 million in NIH research funding Nemours received during the third quarter of 2026, a spokesperson confirmed to Becker’s.